Thermo and NanoPin Announce Collaboration
Thermo Fisher Scientific has announced a collaboration with NanoPin Technologies, Inc. to improve blood-based infectious disease detection technology through the development of highly sensitive LC–MS‑based workflows.
Thermo Fisher Scientific (Waltham, Massachusetts, USA) has announced a collaboration with NanoPin Technologies, Inc. (New Orleans, Louisiana, USA) to improve blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography–mass spectrometry (LC–MS)âbased workflows.
The companies will combine Thermo Fisher’s LC–MS technology with NanoPin’s diagnostic platform to detect disease-related antigens directly from patient blood samples, which will lead to the development of sensitive clinical assays for infectious disease. The overall aim is to reduce diagnosis times and improve the determination of infection stage, as well as monitor patient response to prescribed treatments.
For more information please visit: www.thermofisher.com
Removing Double-Stranded RNA Impurities Using Chromatography
April 8th 2025Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how chromatography can be used to remove double-stranded RNA impurities during mRNA therapeutics production.
The Effect of Time and Tide On PFAS Concentrations in Estuaries
April 8th 2025Oliver Jones and Navneet Singh from RMIT University, Melbourne, Australia discuss a recent study they conducted to investigate the relationship between tidal cycles and PFAS concentrations in estuarine systems, and offer practical advice on the sample preparation and LC–MS/MS techniques they used to achieve the best results.
